Cargando…
Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018
INTRODUCTION: In recent decades, there are multiple reports of lead poisoning in drug abusers in Iran and other Middle East countries. The lead in the mother's blood can cause many dangerous, harmful effects on the mother and the fetus. Therefore, in this study, we evaluated the blood lead leve...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559079/ https://www.ncbi.nlm.nih.gov/pubmed/31198732 http://dx.doi.org/10.4103/jfmpc.jfmpc_36_19 |
_version_ | 1783425763100327936 |
---|---|
author | Rezaie, Mehrdad Abolhassanzadeh, Seyedeh Zarrin Haghighinejad, Hourvash |
author_facet | Rezaie, Mehrdad Abolhassanzadeh, Seyedeh Zarrin Haghighinejad, Hourvash |
author_sort | Rezaie, Mehrdad |
collection | PubMed |
description | INTRODUCTION: In recent decades, there are multiple reports of lead poisoning in drug abusers in Iran and other Middle East countries. The lead in the mother's blood can cause many dangerous, harmful effects on the mother and the fetus. Therefore, in this study, we evaluated the blood lead level (BLL) in pregnant women who were an illegal drug user and compared it with pregnant women who did not use these agents. METHOD: A cross-sectional study was conducted among 60 pregnant women referred to Shiraz Hazrat Zinab and Hafez Hospitals. All pregnant women with a history of any drug abuse were sampled. Two pregnant women without any history of drug abuse were sampled for each pregnant mother with a history of drug abuse on the same day. To check BLL, 5 cc blood sample of all participants sent to a reference laboratory. BLLs have been assessed by atomic absorption spectrophotometry with GBC Avanta, and all reports were confirmed by a specific pathologist. The data were completed with maternal demographic information and infants’ anthropometric indices. Data analysis was performed using SPSS software version 24, and the significance was 0.05. RESULTS: There was a significant difference in BLL among pregnant women with and without drug abuse history (9.91 ± 26.2 and 2.95 ± 0.7, respectively) (P-value: 0.001). The prevalence of lead levels of more than 5 μg/dl in mothers with and without substance abuse was 20% and 7.5%, respectively. Anthropometric indices, Apgar score, and gestational age in the mothers with a history of drug abuse were significantly lower than the control group (a significant level less than 0.05). CONCLUSION: The level of lead in pregnant women taking illegal drugs is higher than that of the control group who do not have a history of illegal drug abuse. On the other hand, it is likely that increased serum levels of lead with fetal complications and maternal health threats childbirth and clinical outcomes during childbirth. |
format | Online Article Text |
id | pubmed-6559079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-65590792019-06-13 Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018 Rezaie, Mehrdad Abolhassanzadeh, Seyedeh Zarrin Haghighinejad, Hourvash J Family Med Prim Care Original Article INTRODUCTION: In recent decades, there are multiple reports of lead poisoning in drug abusers in Iran and other Middle East countries. The lead in the mother's blood can cause many dangerous, harmful effects on the mother and the fetus. Therefore, in this study, we evaluated the blood lead level (BLL) in pregnant women who were an illegal drug user and compared it with pregnant women who did not use these agents. METHOD: A cross-sectional study was conducted among 60 pregnant women referred to Shiraz Hazrat Zinab and Hafez Hospitals. All pregnant women with a history of any drug abuse were sampled. Two pregnant women without any history of drug abuse were sampled for each pregnant mother with a history of drug abuse on the same day. To check BLL, 5 cc blood sample of all participants sent to a reference laboratory. BLLs have been assessed by atomic absorption spectrophotometry with GBC Avanta, and all reports were confirmed by a specific pathologist. The data were completed with maternal demographic information and infants’ anthropometric indices. Data analysis was performed using SPSS software version 24, and the significance was 0.05. RESULTS: There was a significant difference in BLL among pregnant women with and without drug abuse history (9.91 ± 26.2 and 2.95 ± 0.7, respectively) (P-value: 0.001). The prevalence of lead levels of more than 5 μg/dl in mothers with and without substance abuse was 20% and 7.5%, respectively. Anthropometric indices, Apgar score, and gestational age in the mothers with a history of drug abuse were significantly lower than the control group (a significant level less than 0.05). CONCLUSION: The level of lead in pregnant women taking illegal drugs is higher than that of the control group who do not have a history of illegal drug abuse. On the other hand, it is likely that increased serum levels of lead with fetal complications and maternal health threats childbirth and clinical outcomes during childbirth. Wolters Kluwer - Medknow 2019-05 /pmc/articles/PMC6559079/ /pubmed/31198732 http://dx.doi.org/10.4103/jfmpc.jfmpc_36_19 Text en Copyright: © 2019 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Rezaie, Mehrdad Abolhassanzadeh, Seyedeh Zarrin Haghighinejad, Hourvash Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018 |
title | Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018 |
title_full | Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018 |
title_fullStr | Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018 |
title_full_unstemmed | Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018 |
title_short | Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018 |
title_sort | comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to shiraz university hospitals in 2017-2018 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559079/ https://www.ncbi.nlm.nih.gov/pubmed/31198732 http://dx.doi.org/10.4103/jfmpc.jfmpc_36_19 |
work_keys_str_mv | AT rezaiemehrdad comparingserumleadlevelindrugabusepregnantwomenwithnonaddictedpregnantmothersreferringtoshirazuniversityhospitalsin20172018 AT abolhassanzadehseyedehzarrin comparingserumleadlevelindrugabusepregnantwomenwithnonaddictedpregnantmothersreferringtoshirazuniversityhospitalsin20172018 AT haghighinejadhourvash comparingserumleadlevelindrugabusepregnantwomenwithnonaddictedpregnantmothersreferringtoshirazuniversityhospitalsin20172018 |